-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES LILLY'S MOUNJARO (TIRZEPATIDE) TO REDUCE CARDIOVASCULAR RISK IN ADULTS WITH TYPE 2 DIABETES

Reuters·08/28/2026 11:00:04

Please log in to view news